South Africa in talks with Pfizer, Merck for COVID pills amid Omicron concerns

A technician uses a single channel pipette dropper at the Testaro Covid-19 laboratory in the Dunkeld suburb of Johannesburg, South Africa. Representative Image | bloomberg

Form of words:

South Africa: South Africa is in talks with Pfizer Inc and Merck & Co to gain access to their COVID-19 treatment pills as the Omron version spreads across the country and cases almost double,

The country wants one of them to potentially produce medical science in South Africa, Nicholas Crisp, deputy director general of South Africa’s health department, said on Wednesday in response to a question from an MP.

“We’re discussing those two and other matters with the manufacturers so that we understand what they’re selling, what it does,” he said.

South Africa has the most confirmed cases of Covid-19 in Africa, with nearly 3 million infections and nearly 90,000 deaths officially attributed to the disease. Omicron’s debut is triggering a fourth wave of infections.

He said that the medicines are being considered by the National List of Essential Medicines Committee for their economic value.

estimated requirement

“We have worked out numbers with our partners in the provinces that we think will be able to use those two drugs,” he said.

Merck and Pfizer are seeking approval from the US Food and Drug Administration for emergency use of their tablets, which are known as molanupiravir and paxlovid respectively.

South Africa on Wednesday recorded 8,561 infections compared to 4,373 a day earlier, according to the National Institute for Communicable Diseases. ,bloomberg


Read also: Omicron needs 3 evolutionary surprises to wreak havoc


subscribe our channel youtube And Wire

Why is the news media in crisis and how can you fix it?

India needs free, unbiased, non-hyphenated and questionable journalism even more as it is facing many crises.

But the news media itself is in trouble. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, crude prime-time spectacle.

ThePrint has the best young journalists, columnists and editors to work for it. Smart and thinking people like you will have to pay a price to maintain this quality of journalism. Whether you live in India or abroad, you can Here,

support our journalism